Search For "moderate"
Mildly symptomatic COVID patients to be admitted in Category II, III hospi
Updated : 5 years, 7 months ago IST
Srinagar (Jammu and Kashmir) [India], July 28 (ANI): The Jammu and Kashmir Government on Tuesday said that COVID-19 patients with mild and moderate level hospitals should be admitted into category II/III hospitals at the sub-district/district level.
Read More
Moderate rainfall with occasionally intense spells likely over parts of In
Updated : 5 years, 7 months ago IST
New Delhi [India], July 28 (ANI): Moderate rainfall with occasionally intense spell likely to occur over Gangetic West Bengal and adjoining north Coastal Odisha, north Coastal Andhra Pradesh and adjoining Telangana, Lakshadweep, Tamil Nadu, Konkan and Goa during next three-four hours, as per
Read More
COVID-19: Health ministry decides not to put Itolizumab in national treatm
Updated : 5 years, 7 months ago IST
New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe COVID-19 patients, the Union Health Ministry has decided not to include the drug in the national treatment protocol for co
Read More
Isolated to scattered to light-moderate rain likely over Karnataka: KSNDMC
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 26 (ANI): Isolated to scattered to light-moderate rains are likely over Karnataka on Sunday, informed the Karnataka State Natural Disaster Monitoring Centre (KSNDMC).
Read More
Scattered light to moderate rains likely over Karnataka: KSNDMC
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 25 (ANI): Scattered light to moderate rains are likely to occur over state capital Bengaluru and other regions in Karnataka for the next two days, the Karnataka State Natural Disaster Monitoring Centre (KSNDMC) said on Saturday
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
Glenmark announces top-line results from phase 3 clinical trial of Favipir
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
Read More
COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3
Updated : 5 years, 7 months ago IST
New Delhi [India], July 22 (ANI): Domestic pharma giant Glenmark pharmaceuticals on Thursday announced the positive outcomes from a Phase 3 clinical trial conducted across seven clinical sites in India, where COVID-19 patients administered with Favipiravir reported faster clinical cure an
Read More
Light to moderate rainfall very likely over North and South Goa
Updated : 5 years, 8 months ago IST
Panaji (Goa) [India], July 18 (ANI): Light to moderate spells of rain are likely to occur at most parts of North Goa and South Goa districts during the next three hours (from 02:15 pm onwards), the Meteorological Centre, Goa informed on Saturday.
Read More
Thunderstorm, rain likely in parts of Uttarakhand, Haryana:IMD
Updated : 5 years, 8 months ago IST
New Delhi [India], July 18 (ANI): Moderate rainfall or thundershowers are very likely to occur in parts of Uttarakhand, North Rajasthan, northeastern states along with other regions on Saturday, India Meteorological Department (IMD) said.
Read More
Light to moderate rainfall very likely in parts of Himachal Pradesh
Updated : 5 years, 8 months ago IST
Shimla (Himachal Pradesh) [India], July 17 (ANI): Light to moderate rainfall or thundershowers are very likely to occur in parts of Himachal Pradesh on Friday, India Meteorological Department (IMD) said.
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More